Aptevo Therapeutics Inc. Payments to Acquire Investments
Aptevo Therapeutics Inc. (APVO) reported Payments to Acquire Investments of $16.54 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2020-03-25
- Aptevo Therapeutics Inc. payments to acquire investments for the quarter ending 2018-12-31 was $1.00K, a 100.00% decline year-over-year.
- Aptevo Therapeutics Inc. payments to acquire investments for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Aptevo Therapeutics Inc. payments to acquire investments for the quarter ending 2018-06-30 was $14.54M, a 10209.22% increase year-over-year.
- Aptevo Therapeutics Inc. payments to acquire investments for the quarter ending 2018-03-31 was $2.00M, a 80.29% decline year-over-year.
- Aptevo Therapeutics Inc. payments to acquire investments for fiscal 2018 was $16.54M, a 83.40% decline from fiscal 2017.
- Aptevo Therapeutics Inc. payments to acquire investments for fiscal 2017 was $99.63M, a 121.99% increase from fiscal 2016.
- Aptevo Therapeutics Inc. payments to acquire investments for fiscal 2016 was $44.88M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $1.00K derived: sum of 2 quarters · filed 2020-03-25 | $14.54M derived: sum of 3 quarters · filed 2020-03-25 | $16.54M 10-K · filed 2020-03-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $14.54M derived: sum of 2 quarters · filed 2019-11-07 | $16.53M 10-Q · filed 2019-11-07 | $86.88M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $14.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $16.53M 10-Q · filed 2019-08-09 | $86.88M derived: sum of 3 quarters · filed 2019-08-09 | $105.89M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $2.00M 10-Q · filed 2019-05-09 | $72.34M derived: sum of 2 quarters · filed 2019-05-09 | $91.35M derived: sum of 3 quarters · filed 2019-05-09 | $91.49M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $70.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $89.35M derived: sum of 2 quarters · filed 2019-03-18 | $89.50M derived: sum of 3 quarters · filed 2019-03-18 | $99.63M 10-K · filed 2019-03-18 |
| 2017-09-30 | $19.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $19.15M derived: sum of 2 quarters · filed 2018-11-14 | $29.29M 10-Q · filed 2018-11-14 | $24.37M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $10.28M 10-Q · filed 2018-08-09 | $5.36M derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | $10.14M 10-Q · filed 2018-05-10 | $5.22M derived: sum of 2 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $44.88M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | $49.80M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |